These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 28012685

  • 21. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing.
    Tam KK, Leung KS, Siu GK, Chang KC, Wong SS, Ho PL, Leung EK, Yam WC.
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt.
    Ismail S, Al Amry K, Aggor G, El Naggar H, Selim S.
    Int J Mycobacteriol; 2019 Aug; 8(3):211-217. PubMed ID: 31512595
    [Abstract] [Full Text] [Related]

  • 24. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
    Pierre-Audigier C, Surcouf C, Cadet-Daniel V, Namouchi A, Heng S, Murray A, Guillard B, Gicquel B.
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
    [Abstract] [Full Text] [Related]

  • 25. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
    Huang HT, Lin WH, Chan TH, Jou R.
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869
    [Abstract] [Full Text] [Related]

  • 26. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP, Maro A, Pholwat S, Mpagama SG, Gratz J, Liyoyo A, Houpt ER, Kibiki GS, Mmbaga BT, Heysell SK.
    BMC Infect Dis; 2019 Feb 07; 19(1):129. PubMed ID: 30732572
    [Abstract] [Full Text] [Related]

  • 27. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM, Ahmad S, Mokaddas E.
    Microb Drug Resist; 2018 Sep 07; 24(7):923-931. PubMed ID: 29336677
    [Abstract] [Full Text] [Related]

  • 28. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F, Khosravi AD, Farnia P.
    Microb Drug Resist; 2009 Dec 07; 15(4):251-6. PubMed ID: 19857130
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW, Mon AS, Htwe MM, Win SM, Aye KT, San LL, Zaw NN, Nyunt WW, Myint Z, Lee JS, Aung WW.
    Tuberculosis (Edinb); 2020 Dec 07; 125():102013. PubMed ID: 33142220
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G, “Union short MDR-TB regimen study group”.
    PLoS One; 2017 Dec 07; 12(10):e0187211. PubMed ID: 29088294
    [Abstract] [Full Text] [Related]

  • 35. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
    Hong CY, Wang F, Gui J, Liu XL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May 07; 46(5):436-9. PubMed ID: 22883731
    [Abstract] [Full Text] [Related]

  • 36. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A, Kozhamkulov U, Bismilda V, Chingissova L, Abildaev T, Dymova M, Filipenko M, Ramanculov E.
    Int J Tuberc Lung Dis; 2015 Feb 07; 19(2):179-84. PubMed ID: 25574916
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y, Mathema B, Zhao Q, Zheng X, Li D, Jiang W, Wang W, Xu B.
    Tuberculosis (Edinb); 2016 Mar 07; 97():18-25. PubMed ID: 26980491
    [Abstract] [Full Text] [Related]

  • 38. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    Naluyange R, Mboowa G, Komakech K, Semugenze D, Kateete DP, Ssengooba W.
    PLoS One; 2020 Mar 07; 15(5):e0232543. PubMed ID: 32413052
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S, Fonseca Lde S, Marsico AG, de Oliveira Vieira GB, Sobral LF, Stehr M, Singh M, Saad MH.
    Infect Genet Evol; 2013 Oct 07; 19():1-6. PubMed ID: 23770140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.